Aging

Paulo J. Oliveira, PhD received his Bachelor of Science in Biochemistry and his PhD in Cellular Biology from the Universidade de Coimbra, Portugal. Dr. Oliveira spent more than three years working at the Medical School of the University of Minnesota, Duluth, USA, where he collaborated with several researchers and contributed to the publication of several peer-reviewed manuscripts. Besides research, Dr. Oliveira is often involved in teaching at the Department of Life Sciences, University of Coimbra, as well as in other Universities in Portugal and elsewhere. He has maintained a consistent primary role in the organization of national and international scientific meetings and is currently the President of the European Society for Clinical Investigation. He has over 200 peer-reviewed publications and is currently one of the most well-known researchers in this area, with collaboration with researchers in Europe, Africa and in the USA. He has also been a reviewer for more than 40 different scientific journals and over 10 different funding agencies, including the European Commission (Research Executive Agency) and the Portuguese Foundation for Science and Technology. João O. Malva, PhD received his PhD in Cell Biology at the University of Coimbra 1997. He is a Principal Investigator at the Faculty of Medicine of the University of Coimbra (FMUC). He is the Director of the Project Management Unit and Science Coordinator as well as the Secretary of the Assembly at FMUC. Dr. Malva is also the Vice-Director of the Interdisciplinary Research Institute and the Science Coordinator for the consortium “Ageing@Coimbra” – European Reference Site for Active and Healthy Ageing. He is a past President of the Portuguese Society for Neuroscience (2007-2011). His research activity has been focused on Neuroscience with relevant contributions in areas such as neuroprotection, neuroinflammation and neurogenesis in brain repair. He has significant international visibility, including a nomination as full member to EDAB (European DANA Alliance for the Brain).

• Section 1. The Societal Burden of Aging1. Aging at a global level2. The financial and economical burden of aging worldwide3. Flagship initiatives for healthy living and active aging in Europe4. Flagship initiatives for healthy living and active aging in Africa5. Flagship initiatives for healthy living and active aging in North America6. Flagship initiatives for healthy living and active aging in Asia and Oceania7. Flagship initiatives for healthy living and active aging in Central and South AmericaSection 2. The Biology of Aging8. A metabolic and mitochondrial angle on aging9. Intracellular communication and aging10. Genomic instability and telomere attrition11. Cellular senescence during aging12. The epigenetics of aging13. Disrupted cellular quality control mechanisms in aging14. Deregulated nutrient sensing in aging15. Stem cells fitness and aging16. Programming of early agingSection 3. Aging-related physiology, disease and prevention of aging-related diseases17. Adherence to therapy and polymedication18. Frailty and cognitive decline19. Cardiovascular aging20. Aging-related neoplasia21. Inflammation22. Geroscience: An unifying view on aging as a risk factor23. Building healthy agingSection 4: The Future and Innovation in Aging24. The future of innovation in aging25. Machine learning in the context of better healthcare in aging26. The knowledge and research in aging for the future27. The future of integrated care in aged individuals28. Moving from reactive to preventive medicine29. Personalized medicine: will this work for decreasing aging-related morbidities30. Anti-aging interventions: myths and realities